Organon & Co.

NYSE:OGN 3:59:50 PM EDT

33.40

+0.75 (+2.30%)

4:00:01 PM EDT: $33.35 -0.05 (-0.15%)

Market Cap (Intraday)	8.47B
Current PE	5.08
Forward PE	5.44
2yr Forward PE	5.48

See more stats

Estimates Current Quarter

Revenue	$1.59 Billion
Adjusted EPS	$1.46

See more estimates

10-Day MA	$33.47
50-Day MA	$32.07
200-Day MA	N/A

See more pivots

Organon & Co. Stock, NYSE:OGN

30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302

Phone: +1.551.430.6900

Number of Employees: 9950

Description

Organon & Co. is a science based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies within womenâ�?��?�s health, biosimilars and established brands. The company was founded on March 11, 2020 and is headquartered in Jersey City, NJ.